OPEN END TURBO LONG - AMGEN | Market Closed - Börse Stuttgart 20:56:32 03/07/2024 BST | ||
| 13.14 EUR | -2.23% |
|
| Current month | -3.45% | ||
| 1 month | +1.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 03/07/24 | 13.14 | -2.23% |
| 02/07/24 | 13.44 | +0.30% |
| 01/07/24 | 13.4 | -1.54% |
| 28/06/24 | 13.61 | +0.15% |
| 27/06/24 | 13.59 | -0.44% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 08:56 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MD5KJF |
| ISIN | DE000MD5KJF8 |
| Date issued | 27/06/2022 |
| Strike | 167.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.91 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.9 € |
|---|---|
| Lowest since issue | 5.46 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.4
USD
Spread / Average Target
+2.28%
- Stock Market
- Certificates
- Certificat
